Potential delays in clinical trials may result in extended timelines for new drug approvals, and a sudden reduction in financial support could also lead to the loss of critical data if research teams ...

The impact will be crippling to biomedical research in the U.S., and institutions will immediately face hard choices about ...

The American Cancer Society's chief scientific officer outlines the group's research agenda, including a new project in ...

Roseman University of Health Sciences in Henderson announced today it has been designated a research institution by the Carnegie Classification. Roseman is the third ...

UNLV was recognized with its third consecutive R1 designation for research excellence from the Carnegie Classification of ...

Cancer researcher Karen Sfanos says she is 'terrified' of the impact of cuts to NIH funding that supports vital biomedical ...

We recently published a list of 11 AI News and Ratings on Investors’ Radar. In this article, we are going to take a look at ...

The donation from philanthropists Catherine and Anthony Clifton will help advance clinical care, education and research at ...

The University of Vermont has joined the ranks of the nation’s top-tier research institutions by achieving an R1 Research ...

Clinical trial complexity, logistical challenges associated with treatments, and resource constraints at trial sites cited as top factors that ...

For the fourth consecutive time, West Virginia University has attained one of the most elite designations for its research ...

Company reported positive Phase 2b QUALITY study topline results for enobosarm + semaglutide (Wegovy®) with study meeting prespecified primary ...